ASX:ANN
Ansell Limited · ASX · Healthcare · AUD · FY for 2026
Figures on this page computed 2026-11-08 12:25 UTC
Last close
n/aAUD
Market data
20.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- computed
- Computed from the filing for 2026
10.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
9.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
13.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
0.38Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- Computed from the filing for 2026
- Computed from the filing for 2026
1.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- AUD
- computed
Growth is the furthest below its sector's middle: 0.41 against 0.47 on the market's range.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.